MENU
+Compare
ONCY
Stock ticker: NASDAQ
AS OF
Jun 26 closing price
Price
$0.72
Change
+$0.03 (+4.35%)
Capitalization
63.4M

ONCY Oncolytics Biotech Forecast, Technical & Fundamental Analysis

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company... Show more

Industry: #Biotechnology
ONCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ONCY with price predictions
Jun 26, 2025

ONCY in upward trend: 10-day moving average moved above 50-day moving average on June 18, 2025

The 10-day moving average for ONCY crossed bullishly above the 50-day moving average on June 18, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 09, 2025. You may want to consider a long position or call options on ONCY as a result. In of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ONCY just turned positive on June 09, 2025. Looking at past instances where ONCY's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

ONCY moved above its 50-day moving average on June 11, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ONCY advanced for three days, in of 200 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ONCY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ONCY broke above its upper Bollinger Band on June 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ONCY entered a downward trend on June 10, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ONCY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (13.514) is normal, around the industry mean (16.566). P/E Ratio (0.000) is within average values for comparable stocks, (58.942). ONCY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.298). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (254.026).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ONCY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ONCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ONCY is expected to report earnings to rise 10.63% to -8 cents per share on August 06

Oncolytics Biotech ONCY Stock Earnings Reports
Q2'25
Est.
$-0.09
Q1'25
Beat
by $0.03
Q4'24
Beat
by $0.02
Q3'24
Missed
by $0.02
Q2'24
Est.
$-0.10
The last earnings report on May 14 showed earnings per share of -7 cents, beating the estimate of -10 cents. With 1.90M shares outstanding, the current market capitalization sits at 63.40M.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products for the treatment of cancers

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
322 11th Avenue S.W
Phone
+1 403 670-7377
Employees
26
Web
https://www.oncolyticsbiotech.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VNRX0.870.11
+14.21%
VolitionRX Limited
SOUN9.920.35
+3.66%
SoundHound AI
KO69.47-0.16
-0.23%
Coca-Cola Company
AAON72.46-0.29
-0.40%
AAON
DIN25.29-0.48
-1.86%
Dine Brands Global

ONCY and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ONCY has been loosely correlated with ABCL. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ONCY jumps, then ABCL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONCY
1D Price
Change %
ONCY100%
+4.80%
ABCL - ONCY
34%
Loosely correlated
-1.58%
SRRK - ONCY
34%
Loosely correlated
-0.92%
RXRX - ONCY
29%
Poorly correlated
+4.65%
VCYT - ONCY
27%
Poorly correlated
+1.36%
FULC - ONCY
26%
Poorly correlated
+3.07%
More